Potential Factor XIII Activity
| Plasma . | 14C-Putrescine Incorporation Into N,N-dimethylcasein (30-minute; cpm) . | ||
|---|---|---|---|
| +Added Thrombin* . | −Added Thrombin* . | ThrombinDependent . | |
| Control | 2,194 (2,122, 2,266) | 136 (136, 135) | 2,058 (100%) |
| Patient (07/31/91) | 1,429 (1,433, 1,425) | 155 (154, 156) | 1,274 (62%) |
| Plasma . | 14C-Putrescine Incorporation Into N,N-dimethylcasein (30-minute; cpm) . | ||
|---|---|---|---|
| +Added Thrombin* . | −Added Thrombin* . | ThrombinDependent . | |
| Control | 2,194 (2,122, 2,266) | 136 (136, 135) | 2,058 (100%) |
| Patient (07/31/91) | 1,429 (1,433, 1,425) | 155 (154, 156) | 1,274 (62%) |
Average; individual values are in parentheses.